Pasithea Therapeutics Corp. (NASDAQ:KTTA – Get Free Report) was the target of a significant decline in short interest during the month of February. As of February 28th, there was short interest totalling 8,700 shares, a decline of 67.4% from the February 13th total of 26,700 shares. Approximately 0.9% of the shares of the company are sold short. Based on an average daily volume of 1,030,000 shares, the short-interest ratio is currently 0.0 days.
Pasithea Therapeutics Price Performance
Shares of NASDAQ:KTTA traded up $0.07 during midday trading on Friday, reaching $1.11. The company had a trading volume of 22,587 shares, compared to its average volume of 532,938. The company’s 50 day moving average price is $1.91 and its 200 day moving average price is $3.13. Pasithea Therapeutics has a 52-week low of $0.92 and a 52-week high of $9.25.
About Pasithea Therapeutics
Read More
- Five stocks we like better than Pasithea Therapeutics
- Election Stocks: How Elections Affect the Stock Market
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What is MarketRank™? How to Use it
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Investing in Commodities: What Are They? How to Invest in Them
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Pasithea Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pasithea Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.